Do you want to read an article? Please log in or register.
Pharmacokinetics of tiotropium administered by Respimat® in asthma patients: Analysis of pooled data from Phase II and III clinical trials
AsthmaCOPD
Related content
RECOMMENDED
Asthma
Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Lemiere C, Taillé C, Lee JK, Smith SG, Mallett S, Albers FC, Bradford ES, Yancey SW, Liu MC
doi: 10.1186/s12931-021-01767-z
RECOMMENDED
Asthma
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Puggioni F, Brussino L, Canonica GW, Blasi F, Paggiaro P, Caminati M, Latorre M, Heffler E, Senna G, Severe Asthma Network in Italy (SANI) group.
doi: 10.2147/JAA.S274245
Asthma
Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype
J Allergy Clin Immunol Pract.
Casale TB, Bateman ED, Vandewalker M, Virchow JC, Schmidt H, Engel M, Moroni-Zentgraf P, Kerstjens HAM
doi: 10.1016/j.jaip.2017.08.037.
Asthma
A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma
Meltzer EO, Berger WE
doi: 10.2500/aap.2018.39.4103.
COMMENTED
Asthma
Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials
J Asthma.
Zayed Y, Kheiri B, Banifadel M, Hicks M, Aburahma A, Hamid K, Bachuwa G, Chandran A
doi: 10.1080/02770903.
Asthma
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma
J Allergy Clin Immunol.
Szefler SJ, Murphy K, Harper T 3rd, Boner A, Laki I, Engel M, El Azzi G, Moroni-Zentgraf P, Finnigan H, Hamelmann E
doi: 10.1016/j.jaci.2017.01.014.
RECOMMENDED
Asthma
Unmet Needs in Severe Asthma Subtyping and Precision Medicine Trials: Bridging Clinical and Patient Perspectives
Am J Respir Crit Care Med.
Siddiqui S, Denlinger LC, Fowler SJ, Akuthota P, Shaw DE, Heaney LG, Brown L, Castro M, Winders TA, Kraft M, Wagers S, Peters MC, Pavord ID, Walker S, Jarjour NN
doi: 10.1164/rccm.
RECOMMENDED
Asthma
Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med.
Casale TB, Aalbers R, Bleecker ER, Meltzer EO, Zaremba-Pechmann L, de la Hoz A, Kerstjens HAM
doi: 10.1016/j.rmed.2019.09.014.
RECOMMENDED
COPD
Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Ther Adv Respir Dis.
Sethi S, Donohue JF, Ferguson GT, Barnes CN, Crater GD
doi: 10.1177/1753466620905278.Visit the original publication at ncbi.nlm.nih.gov